CPHI Milan 2026
10/2026 – 10/2026
DERMAGO
441
14
6
4.8(8)
증거
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
댓글이 없습니다.
Dermago grants licensing rights for its self-developed generic approvals of Advantan/Skinatan and Skinoren/Beloren, as well as exclusive licensing rights for its patent-protected product Veregen.
평가 & 댓글 남기기